Welcome to the e-CCO Library!

Page: 1 2 3 4 ()
Y-ECCO Literature Review: 3g mesalazine granules are superior to 9mg budesonide for achieving remission in active ulcerative colitis: A double-blind, double-dummy, randomized trial.
Source: ECCO News Issue 02/2011
Authors: Anja Schirbel
Y-ECCO Literature Review: A CD3-specific antibody reduces cytokine production and alters phospho-protein profiles in intestinal tissues from patients with Inflammatory Bowel Disease
Source: ECCO News Issue 02/2014
Authors: Raquel Cabezón
Y-ECCO Literature Review: A global consensus on the classification, diagnosis and multidisciplinary treatment of perianal fistulising Crohn’s disease
Source: ECCO News Issue 04/2014
Authors: Nuha Yassin
Y-ECCO Literature Review: A population-based study of fatigue and sleep difficulties in inflammatory bowel disease
Source: ECCO News Issue 04/2011
Authors: Antonina Mikocka-Walus
Y-ECCO Literature Review: A prospective study of long-term intake of dietary fibre and risk of Crohn’s disease and ulcerative colitis
Source: ECCO News Issue 04/2013
Authors: Robin Dart
Y-ECCO Literature Review: Abnormal activation of autophagy-induced crinophagy in Paneth cells from patients with Crohn’s Disease
Source: ECCO News Issue 04/2012
Authors: J. Jasper Deuring
Y-ECCO Literature Review: Adalimumab combined with ciprofloxacin is superior to adalimumab monotherapy in perianal fistula closure in Crohn’s disease: a randomised, doubleblind, placebo-controlled trial (ADAFI)
Source: ECCO News Issue 02/2013
Authors: Ilse Molendijk
Y-ECCO Literature Review: Adalimumab combined with ciprofloxacin is superior to adalimumab monotherapy in perianal fistula closure in Crohn’s disease: a randomised, doubleblind, placebo-controlled trial (ADAFI)
Source: ECCO News Issue 02/2013
Authors: Ilse Molendijk
Y-ECCO Literature Review: AIM2 contributes to the maintenance of intestinal integrity via Akt and protects against Salmonella mucosal infection
Source: ECCO News Issue 02/2016
Authors: Wiebe Vanhove
Y-ECCO Literature Review: Alterations in mucin glycosylation are associated with spontaneous colitis
Source: ECCO News Issue 03/2011
Authors: Sebastian Zeissig
Y-ECCO Literature Review: Anti-IP-10 antibody (BMS-936557) for ulcerative colitis: a phase II randomised study
Source: ECCO News Issue 02/2013
Authors: Dominik Bettenworth
Y-ECCO Literature Review: Antibodies to adalimumab are associated with future inflammation in Crohn’s patients receiving maintenance adalimumab therapy: a post hoc analysis of the Karmiris trial
Source: ECCO News Issue 02/2015
Authors: Nik Sheng Ding
Y-ECCO Literature Review: Atg16L1 T300A variant decreases selective autophagy resulting in altered cytokine signaling and decreased antibacterial defense
Source: ECCO News Issue 03/2014
Authors: Kris Nys
Y-ECCO Literature Review: Bacterial sensor triggering receptor expressed on myeloid cells-2 regulates the mucosal inflammatory response
Source: ECCO News Issue 01/2013
Authors: Gwenny Fuhler
Y-ECCO Literature Review: Cancer recurrence following immune-suppressive therapies in patients with immune-mediated diseases: a systematic review and meta-analysis
Source: ECCO News Issue 02/2016
Authors: Lieke Spekhorst
Y-ECCO Literature Review: Ciclosporin versus infliximab in patients with severe Ulcerative Colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial
Source: ECCO News Issue 01/2013
Authors: Joana Torres
Y-ECCO Literature Review: Combination therapy with infliximab and azathioprine is superior to monotherapy with either agent in Ulcerative Colitis
Source: ECCO News Issue 01/2014
Authors: Jeff Chang
Y-ECCO Literature Review: Comparative effectiveness of immunosuppressant and biologics for inducing and maintaining remission in Crohn’s Disease: A network meta-analysis
Source: ECCO News Issue 04/2014
Authors: Piotr Eder
Y-ECCO Literature Review: Concentrations of 6-thioguanine nucleotide correlate with trough levels of infliximab in patients with inflammatory bowel disease on combination therapy
Source: ECCO News Issue 01/2015
Authors: David Drobne
Y-ECCO Literature Review: Crohn’s Disease management after intestinal resection: a randomised trial
Source: ECCO News Issue 03/2015
Authors: Constantinos Parisinos
Page: 1 2 3 4 ()